XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.4

STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2025

STOCKHOLDERS' EQUITY

Summary of outstanding warrants to purchase common stock

​

​	​	​	​	​	​	​	​
​	​	Number of Common	​	​	​	​	​
​	​	Shares Issuable	​	​	​	​	​
​	​	Upon	​	​	​	​	​
​	​	Exercise of	​	​	​	​	​
​	​	Outstanding	​	Exercise		​	​
Offering	​ ​ ​	Warrants	​ ​ ​	Price		​ ​ ​	Expiration Date
2025 October Series I Common Warrants	​	1,048,094	​	$	6.00	​	October 8, 2030
2025 October Series II Common Warrants	​	1,048,094	​	$	6.00	​	April 8, 2027
2025 July Common Warrants		436.000	​	$	5.25	​	July 2, 2030
2025 Representative Warrants		82,800	​	$	7.75	​	July 2, 2030
2024 Tranche A Warrants	​	114,773	​	$	75.60	​	July 21, 2029
2024 Tranche B Warrants	​	139,877	​	$	120.00	​	July 21, 2029
2024 Tranche C Warrants	​	72,663	​	$	165.00	​	July 21, 2029
2023 Tranche B Preferred Warrants		14,652	​	$	143.25	​	September 8, 2028
2022 Common Warrants		75,939	​	$	58.80	​	October 25, 2027
Total		3,032,892	​		​	​	​

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration